Covid-19 roundup: Study suggests AstraZeneca/Oxford booster is effective against variants — report; IFPMA issues guidance on vaccine inequity
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.